Found 241 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma PHASE2 This study will address the question of whether targeting CMV antigens with...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months PHASE3 This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Show More Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Learn More & Join Trial
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Show More Location
Knight Cancer Institute at Oregon Health and Science University
Learn More & Join Trial
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately PHASE3 This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma PHASE1 This study evaluates whether it is safe to administer a peptide vaccine wit...
Show More Location
Cancer Center at the University of Virginia
Learn More & Join Trial
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. PHASE1 This cancer vaccine research study involves the injection of the NY-ESO-1b ...
Show More Location
Krankenhaus Nordwest
Learn More & Join Trial
A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults PHASE1 Substudy A: The study aims to learn about the safety and effects of two new...
Show More Location
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Malignant Glioma PHASE1 RATIONALE: Vaccines made from peptides and a person's dendritic cells may h...
Show More Location
Jonsson Comprehensive Cancer Center at UCLA
Learn More & Join Trial
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) PHASE3 To evaluate the immune response and the safety of a primary series schedule...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers PHASE1 The purpose of this study is to assess the safety and tolerability of 2 dif...
Show More Location
Multiple Locations
Learn More & Join Trial